In conclusion, we demonstrated that p53-armed telomerase-specific oncolytic adenovirus OBP-702 enhances the anti-tumor efficacy of PD-1 blockade in PDAC tumors via p53-mediated ICD induction and promotion of cytotoxic T cell infiltration. Here, PDCD1 is linked to neoplasm.